MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1126/scitranslmed.abj2109

Медицинская библиотека · Science translational medicine · 2022

Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Kobayashi Hiroki, Looker Helen C, Satake Eiichiro, D'Addio Francesca, Wilson Jonathan M, Saulnier Pierre Jean, Md Dom Zaipul I, O'Neil Kristina, Ihara Katsuhito, Krolewski Bozena, Badger Hannah S, Petrazzuolo Adriana, Corradi Domenico, Galecki Andrzej, Wilson Parker C, Najafian Behzad, Mauer Michael, Niewczas Monika A, Doria Alessandro, Humphreys Benjamin D, Duffin Kevin L, Fiorina Paolo, Nelson Robert G, Krolewski Andrzej S

СтатьяПоддержка исследования: вне правительства СШАResearch Support, N.I.H., IntramuralПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

Circulating proteins associated with transforming growth factor-β (TGF-β) signaling are implicated in the development of diabetic kidney disease (DKD). It remains to be comprehensively examined which of these proteins are involved in the pathogenesis of DKD and its progression to end-stage kidney disease (ESKD) in humans. Using the SOMAscan proteomic platform, we measured concentrations of 25 TGF-β signaling family proteins in four different cohorts composed in total of 754 Caucasian or Pima Indian individuals with type 1 or type 2 diabetes. Of these 25 circulating proteins, we identified neuroblastoma suppressor of tumorigenicity 1 (NBL1, aliases DAN and DAND1), a small secreted protein known to inhibit members of the bone morphogenic protein family, to be most strongly and independently associated with progression to ESKD during 10-year follow-up in all cohorts. The extent of damage to podocytes and other glomerular structures measured morphometrically in 105 research kidney biopsies correlated strongly with circulating NBL1 concentrations. Also, in vitro exposure to NBL1 induced apoptosis in podocytes. In conclusion, circulating NBL1 may be involved in the disease process underlying progression to ESKD, and its concentration in circulation may identify subjects with diabetes at increased risk of progression to ESKD.

Для цитирования: Kobayashi Hiroki, Looker Helen C, Satake Eiichiro, D'Addio Francesca, Wilson Jonathan M, Saulnier Pierre Jean, Md Dom Zaipul I, O'Neil Kristina, Ihara Katsuhito, Krolewski Bozena, Badger Hannah S, Petrazzuolo Adriana, Corradi Domenico, Galecki Andrzej, Wilson Parker C, Najafian Behzad, Mauer Michael, Niewczas Monika A, Doria Alessandro, Humphreys Benjamin D, Duffin Kevin L, Fiorina Paolo, Nelson Robert G, Krolewski Andrzej S. Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.. Science translational medicine. 2022. DOI: 10.1126/scitranslmed.abj2109.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.